Cardiovascular disease in transplant recipients: Current and future treatment strategies

Clinical Journal of the American Society of Nephrology

Volumn 3, Issue SUPPL. 2, 2008, Pages

  Gill, John S ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; HUMAN; KIDNEY TRANSPLANTATION; POSTOPERATIVE COMPLICATION; REVIEW; RISK FACTOR; RISK REDUCTION;

CARDIOVASCULAR DISEASES; HUMANS; KIDNEY TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; RISK REDUCTION BEHAVIOR;

EID: 41749097053     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02690707     Document Type: Article

References (86)

1. Meier-Kriesche HU, Ojo AO, Port FK, Amdorfer JA, Cibrik DM, Kaplan B: Survival improvement among patients with end-stage renal disease: Trends over time for transplant recipients and wait-listed patients. J Am Soc Nephrol 12: 1293-1296, 2001
2. ANZDATA Registry Report 2006: Australia and New Zealand Dialysis and Transplant Registry, Adelaide, South Australia, 2006
3. USRDS: Annual Data Report: Atlas of End Stage Renal Disease in the United States, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2005
4. Kasiske BL, Chakkera HA, Roel J: Explained and unexplained ischemic heart disease risk after renal transplantation: Epidemiology of cardiovascular disease after renal transplantation. J Am Soc Nephrol 11: 1735-1743, 2000
5. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42: 1206-1252, 2004
6. Kasiske BL, Anjum S, Shah R, Skogen J, Kandaswamy C, Danielson B, O'Shaughnessy EA, Dahl DC, Silkensen JR, Sahadevan M, Snyder JJ: Hypertension after kidney transplantation. Am J Kidney Dis 43: 1071-1081, 2004
7. Cosio FG, Dillon JJ, Falkenhain ME, Tesi RJ, Henry ML, Elkhammas EA, Davies EA, Bumgardner GL, Ferguson RM: Racial differences in renal allograft survival: The role of systemic hypertension. Kidney Int 47: 1136-1141, 1995
8. First MR, Neylan JF, Rocher LL, Tejani A: Hypertension after renal transplantation. J Am Soc Nephrol 4[Suppl]: S30-S36, 1994
9. Curtis JJ: Cyclosporine and posttransplant hypertension. J Am Soc Nephrol 2[Suppl]: S243-S245, 1992
10. Bantle JP, Nath KA, Sutherland DE, Najarian JS, Ferris TF: Effects of cyclosporine on the renin-angiotensin-aldosterone system and potassium excretion in renal transplant recipients. Arch Intern Med 145: 505-508, 1985
11. Bennett WM: Insights into chronic cyclosporine nephrotoxicity. Int J Clin Pharmacol Ther 34: 515-519, 1996
12. Lanese DM, Conger JD: Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles. J Clin Invest 91: 2144-2149, 1993
13. Zhang R, Leslie B, Boudreaux JP, Frey D, Reisin E: Hypertension after kidney transplantation: Impact, pathogenesis and therapy. Am J Med Sci 325: 202-208, 2003
14. Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, Tuttle K, Douglas J, Hsueh W, Sowers J: Preserving renal function in adults with hypertension and diabetes: A consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 36: 646-661, 2000
15. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV. 5.2. Cardiovascular risks. Arterial hypertension. Nephrol Dial Transplant 17: 25-26, 2002
16. Kasiske BL, Vazquez MA, Harmon WE, Brown RS, Danovitch GM, Gaston RS, Roth D, Scandling JD, Singer GG: Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol 11[Suppl 15]: S1-S86, 2000
17. Midtvedt K, Hartmann A, Foss A, Fauchald P, Nordal KP, Rootwelt K, Holdaas H: Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril. Transplantation 72: 1787-1792, 2001
18. Brenner B, Garcia D, Anderson S: Glomeruli and blood pressure, less of one, more of the other. Am J Hypertens 1: 335-347, 1988
19. Wright JT Jr, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, Rostand SG: Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial. JAMA 288: 2421-2431, 2002
20. Agodoa LY, Appel L, Bakris GL, Beck G, Bourgoignie J, Briggs JP, Charleston J, Cheek D, Cleveland W, Douglas JG, Douglas M, Dowie D, Faulkner M, Gabriel A, Gassman J, Greene T, Hall Y, Hebert L, Hiremath L, Jamerson K, Johnson CJ, Kopple J, Kusek J, Lash J, Lea J, Lewis JB, Lipkowitz M, Massry S, Middleton J, Miller ER 3rd, Norris K, O'Connor D, Ojo A, Phillips RA, Pogue V, Rahman M, Randall OS, Rostand S, Schulman G, Smith W, Thornley-Brown D, Tisher CC, Toto RD, Wright JT Jr, Xu S: Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: A randomized controlled trial. JAMA 285: 2719-2728, 2001
21. de Champlain J, Karas M, Nguyen P, Cartier P, Wistaff R, Toal CB, Nadeau R, Larochelle P: Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients. J Hypertens 16: 1357-1369, 1998
22. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Collaborative Research Group. JAMA 283: 1967, 2000
23. Bakris G, Weir M, DeQuatro V, McMahon F: Effects of ACE inhibitor/ calcium antagonist combination on proteinuria in diabetic nephropathy. Kidney Int 54: 1283-1289, 1998
24. Omoto K, Tanabe K, Tokumoto T, Shimmura H, Ishida H, Toma H: Use of candesartan cilexetil decreases proteinuria in renal transplant patients with chronic allograft dysfunction. Transplantation 76: 1170-1174, 2003
25. Inigo P, Campistol JM, Saracho R, Del Castillo D, Anaya F, Esforzado N, Navarro MD, Oppenheimer F: Renoprotective effects of losartan in renal transplant recipients. Results of a retrospective study. Nephron Clin Pract 95: c84-c90, 2003
26. Campistol JM, Inigo P, Jimenez W, Lario S, Clesca PH, Oppenheimer F, Rivera F: Losartan decreases plasma levels of TGF-beta1 in transplant patients with chronic allograft nephropathy. Kidney Int 56: 714-719, 1999
27. del Castillo D, Campistol JM, Guirado L, Capdevilla L, Martinez JG, Pereira P, Bravo J, Perez R: Efficacy and safety of losartan in the treatment of hypertension in renal transplant recipients. Kidney Int Suppl 68: S135-S139, 1998
28. Hiremath S, Fergusson D, Doucette S, Mulay AV, Knoll GA: Renin angiotensin system blockade in kidney transplantation: A systematic review of the evidence. Am J Transplant 7: 2350-2360, 2007
29. Knoll GA, Cantarovitch M, Cole E, Gill J, Gourishankar S, Holland D, Kiberd B, Muirhead N, Prasad R, Tibbles LA, Treleaven D, Fergusson D: The Canadian ACE-inhibitor trial to improve renal outcomes and patient survival in kidney transplantation study design. Nephrol Dial Transplant September 10, 2007 [epub ahead of print]
30. Kasiske BL: Clinical practice guidelines for managing dyslipidemias in kidney transplant patients. Am J Transplant 5: 1576, 2005
31. Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486-2497, 2001
32. Pham PT, Pham PC, Danovitch GM: Cardiovascular disease posttransplant. Semin Nephrol 27: 430-444, 2007
33. Holdaas H, Fellstrom B, Jardine AG, Holme I, Nyberg G, Fauchald P, Gronhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambuhl P, Olsson AG, Hartmann A, Solbu DO, Pedersen TR: Effect of fluvastatin on cardiac outcomes in renal transplant recipients: A multicentre, randomised, placebo-controlled trial. Lancet, 361: 2024-2031, 2003
34. Cosio FG, Pesavento TE, Osei K, Henry ML, Ferguson RM: Post-transplant diabetes mellitus: Increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int 59: 732-737, 2001
35. Cosio FG, Pesavento TE, Kim S, Osei K, Henry M, Ferguson RM: Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int 62: 1440-1446, 2002
36. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ: Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 3: 178-185, 2003
37. Lindholm A, Albrechtsen D, Frodin L: Ischemic heart disease: Major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation 60: 451-457, 1995
38. Fernandez-Fresnedo G, Escallada R, de Francisco AL, Rodrigo E, Zubimendi JA, Ruiz JC, Pinera C, Herraez I, Arias M: Posttransplant diabetes is a cardiovascular risk factor in renal transplant patients. Transplant Proc 35: 700, 2003
39. Reisaeter AV, Hartmann, A: Risk factors and incidence of posttransplant diabetes mellitus. Transplant Proc 33[Suppl]: 8S-18S, 2001
40. Bloom RD, Rao V, Weng F, Grossman RA, Cohen D, Mange KC: Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus. J Am Soc Nephrol 13: 1374-1380, 2002
41. Vincenti F, Friman S, Scheuermann E, Rostaing L, Jenssen T, Campistol JM, Uchida K, Pescovitz MD, Marchetti P, Tuncer M, Citterio F, Wiecek A, Chadban S, El-Shahawy M, Budde K, Goto N: Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 7: 1506-1514
42. Davidson J, Wilkinson A, Dantal J, Dotta F, Haller H, Hernandez D, Kasiske BL, Kiberd B, Krentz A, Legendre C, Marchetti P, Markell M, van der Woude FJ, Wheeler DC: New-onset diabetes after transplantation: 2003 international consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation 75[Suppl]: SS3-SS24, 2003
43. Kasiske BL, Klinger D: Cigarette smoking in renal transplant recipients. J Am Soc Nephrol 11: 753-759, 2000
44. Friedman AN, Miskulin DC, Rosenberg IH, Levey AS: Demographics and trends in overweight and obesity in patients at time of kidney transplantation. Am J Kidney Dis 41: 480-487, 2003
45. Matas AJ, Kandaswamy R, Gillingham KJ, McHugh L, Ibrahim H, Kasiske B, Humar A: Prednisone-free maintenance immunosuppression: A 5-year experience. Am J Transplant 5: 2473-2478, 2005
46. Cole E, Landsberg D, Russell D, Zaltzman J, Kiberd B, Caravaggio C, Vasquez AR, Halloran P: A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients. Transplantation 72: 8455-850, 2001
47. Sivaraman P, Nussbaumer G, Landsberg D: Lack of long-term benefits of steroid withdrawal in renal transplant recipients. Am J Kidney Dis 37: 1162-1169, 2001
48. Alexander JW, Goodman HR, Gersin K, Cardi M, Austin J, Goel S, Safdar S, Huang S, Woodle ES: Gastric bypass in morbidly obese patients with chronic renal failure and kidney transplant. Transplantation 78: 469-474, 2004
49. Newcombe V, Blanch A, Slater GH, Szold A, Fielding GA: Laparoscopic adjustable gastric banding prior to renal transplantation. Obes Surg 15: 567-570, 2005
50. Fernandez-Fresnedo G, Plaza JJ, Sanchez-Plumed J, Sanz-Guajardo A, Palomar-Fontanet R, Arias M: Proteinuria: A new marker of long-term graft and patient survival in kidney transplantation. Nephrol Dial Transplant 19: III47-III51, 2004
51. Roodnat JI, Mulder PG, Rischen-Vos J, van Riemsdijk IC, van Gelder T, Zietse R, IJzermans JN, Weimar W: Proteinuria after renal transplantation affects not only graft survival but also patient survival. Transplantation 72: 438-444, 2001
52. Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen JS: Urinary albumin excretion: An independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 19: 1992-1997, 1999
53. Wachtell K, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlof B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristianson K, Lederballe-Pedersen O, Nieminen MS, Okin PM, Omvik P, Oparil S, Wedel H, Snapinn SM, Aurup P: Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: The LIFE study. Ann Intern Med 139: 901-906, 2003
54. Ibsen H, Olsen MH, Wachtell K, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlof B, Devereux RB, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wan Y: Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: Losartan intervention for endpoint reduction in hypertension study. Hypertension 45: 198-202, 2005
55. IV. Clinical practice recommendations for anemia in chronic kidney disease in transplant recipients. Am J Kidney Dis 47[Suppl]: S109-S116, 2006
56. Rigatto C, Parfrey P, Foley R, Negrijn C, Tribula C, Jeffery J: Congestive heart failure in renal transplant recipients: Risk factors, outcomes, and relationship with ischemic heart disease. J Am Soc Nephrol 13: 1084-1090, 2002
57. Rigatto C, Foley R, Jeffery J, Negrijn C, Tribula C, Parfrey P: Electrocardiographic left ventricular hypertrophy in renal transplant recipients: Prognostic value and impact of blood pressure and anemia relationship with ischemic heart disease. J Am Soc Nephrol 14: 462-468, 2003
58. Imoagene-Oyedeji AE, Rosas SE, Doyle AM, Goral S, Bloom RD: Posttransplantation anemia at 12 months in kidney recipients treated with mycophenolate mofetil: Risk factors and implications for mortality. J Am Soc Nephrol 17: 3240-3247, 2006
59. KDOQI clinical practice guideline and clinical practice reccommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis 50: 471-530, 2007
60. Ducloux D, Motte G, Massy ZA: Hyperhomocyst(e)inemia as a risk factor after renal transplantation. Ann Transplant 6: 40-42, 2001
61. Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, Rasmussen K: Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354: 1578-1588, 2006
62. Bostom AG, Carpenter MA, Kusek JW, Hunsicker LG, Pfeffer MA, Levey AS, Jacques PF, McKenney J: Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trial. Am Heart J 152: 448.e1-448.e7, 2006
63. Winkelmayer WC, Lorenz M, Kramar R, Fodinger M, Horl WH, Sunder-Plassmann G: C-reactive protein and body mass index independently predict mortality in kidney transplant recipients. Am J Transplant 4: 1148-1154, 2004
64. Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH, Pfeffer MA, Braunwald E: C-reactive protein levels and outcomes after statin therapy. N Engl J Med 352: 20-28, 2005
65. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, Zeeuw D, Hostetter TH, Lameire N, Eknoyan G: Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67: 2089-2100, 2005
66. Abbud-Filho M, Adams PL, Alberu J, Cardella C, Chapman J, Cochat P, Cosio F, Danovith G, Davis C, Gaston RS, Humar A, Hunsicker LG, Josephson MA, Kasiske B, Kirste G, Leichtman A, Munn S, Obrador GT, Tibell A, Wadstrom J, Zeier M, Delmonico FL: A report of the Lisbon Conference on the care of the kidney transplant recipient. Transplantation 83[Suppl]: S1-S22, 2007
67. Cosio FG, Alamir A, Yim S, Pesavento TE, Falkenhain ME, Henry ML, Elkhammas EA, Davies EA, Bumgardner GL, Ferguson RM: Patient survival after renal transplantation: I. The impact of dialysis pre-transplant. Kidney Int 53: 767-772, 1998
68. Kasiske BL, Snyder JJ, Matas AJ, Ellison MD, Gill JS, Kausz AT: Preemptive kidney transplantation: The advantage and the advantaged. J Am Soc Nephrol 13: 1358-1364, 2002
69. Meier-Kriesche HU, Port FK, Ojo AO, Rudich SM, Hanson JA, Cibrik DM, Leichtman AB, Kaplan B: Effect of waiting time on renal transplant outcome. Kidney Int 58: 1311-1317, 2000
70. Mange KC, Joffe MM, Feldman HI: Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. N Engl J Med 344: 726-731, 2001
71. Kasiske B, London W, Ellison M: Race and socioeconomic factors influencing early placement on the kidney transplant waiting list. J Am Soc Nephrol 9: 2142-2147, 1998
72. Cass A, Cunningham J, Snelling P, Ayanian JZ: Late referral to a nephrologist reduces access to renal transplantation. Am J Kidney Dis 42: 1043-1049, 2003
73. Weng FL, Mange KC: A comparison of persons who present for preemptive and nonpreemptive kidney transplantation. Am J Kidney Dis 42: 1050-1057, 2003
74. Meier-Kriesche HU, Schold JD, Srinivas TR, Reed A, Kaplan B: Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease. Am J Transplant 4: 1662-1668, 2004
75. Gill JS, Tonelli M, Johnson N, Kiberd B, Landsberg D, Pereira BJ: The impact of waiting time and comorbid conditions on the survival benefit of kidney transplantation. Kidney Int 68: 2345-2351, 2005
76. Covic A, Gusbeth-Tatomir P, Mardare N, Buhaescu I, Goldsmith DJ: Dynamics of the circadian blood pressure profiles after renal transplantation. Transplantation 80: 1168-1173, 2005
77. Riess K, GS, Oreopoulos A, Jones LW, McGavock J, Lewanczuk R, Haykowsky M: Impaired arterial compliance and aerobic endurance in kidney transplant recipients. Transplantation 82: 920-923, 2006
78. Simmons EM, Langone A, Sezer MT, Vella JP, Recupero P, Morrow JD, Ikizler TA, Himmelfarb J: Effect of renal transplantation on biomarkers of inflammation and oxidative stress in end-stage renal disease patients. Transplantation 79: 914-919, 2005
79. Cueto-Manzano AM, Morales-Buenrostro LE, Gonzalez-Espinoza L, Gonzalez-Tableros N, Martin-del-Campo F, Correa-Rotter R, Valera I, Alberu J: Markers of inflammation before and after renal transplantation. Transplantation 80: 47-51, 2005
80. Rosas SE, Mensah K, Weinstein RB, Bellamy SL, Rader DJ: Coronary artery calcification in renal transplant recipients. Am J Transplant 5: 1942-1947, 2005
81. Hernandez D, Gonzalez A, Rufino M, Laynez I, Rosa AD, Porrini E, Lacalzada J, Barragan A, Lorenzo V, Torres A: Time-dependent changes in cardiac growth after kidney transplantation: The impact of pre-dialysis ventricular mass. Nephrol Dial Transplant 22: 2678-2685, 2007
82. Montanaro D, Gropuzzo M, Tulissi P, Vallone C, Boscutti G, Mioni R, Risaliti A, Baccarani U, Adani GL, Sainz M, Lorenzin D, Bresadola F, Mioni G: Effects of successful renal transplantation on left ventricular mass. Transplant Proc 37: 2485-2487, 2005
83. USRDS: Annual Data Report: Atlas of End Stage Renal Disease in the United States, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2005. Available at: http://www.usrds.org/2005/slides/html/06_morb_morte_05_files/ v3_document.htm. Accessed November 25, 2007
84. Gill JS, Rose C, Pereira BJ, Tonelli M: The importance of transitions between dialysis and transplantation in the care of end-stage renal disease patients. Kidney Int 71: 442-447, 2007
85. Kasiske BL, Maclean JR, Snyder JJ: Acute myocardial infarction and kidney transplantation. J Am Soc Nephrol 17: 900-907, 2006
86. Johnston O, Zalunardo N, Rose C, Gill JS: Prevention of sepsis during the transition to dialysis may improve the survival of transplant failure patients. J Am Soc Nephrol 18: 1331-1337, 2007